Medicine

A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

G. Piazza, Benjamin Hohlfelder, M. Jaff, K. Ouriel, T. Engelhardt, K. Sterling, N. Jones, J. Gurley, R. Bhatheja, R. Kennedy, Nilesh Goswami, K. Natarajan, J. Rundback, Immad R. Sadiq, Stephen K. Liu, N. Bhalla, M. L. Raja, B. Weinstock, J. Cynamon, F. Elmasri, Mark J. Garcia, Mark H. Kumar, J. Ayerdi, P. Soukas, W. Kuo, Ping-Yu Liu, S. Goldhaber, Seattle Ii Investigators

2015.8.24JACC-Cardiovascular Interventions

DOI: 10.1016/j.jcin.2015.04.020

tlooto Summary

Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis decreased RV dilation, reduced pulmonary hypertension, decreased anatomic thrombus burden, and minimized intracranial hemorrhage in patients with acute massive and submassive PE.

Abstract

Abstract is not available.

Citation format

PIAZZA, G., et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: The SEATTLE II study. JACC-Cardiovascular Interventions, 2015, 8 10: 1382–92.